Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Relationship Between Computer and Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Guangdong General Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Guangdong General Hospital
ClinicalTrials.gov Identifier:
NCT01043107
First received: January 5, 2010
Last updated: February 4, 2010
Last verified: January 2010
  Purpose

Thyroid Cancer is one of the most common malignant carcinomas. The incidence of thyroid cancer has risen in the past years. The recrudesce rate is highly raised. Computer is widely used by people nowadays, is it a predisposing factor to the highly raised recrudesce rate? This research observed two random assigned groups, in which the patients were diagnosed by pathologic results. One group were strictly prohibit with using computer, the other were not told. Finally collect the recrudesce rate of each group, analyze the data by statistic software.


Condition
Thyroid Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Study on the Relationship Between The Computer Radiation and The Recrudesce Rate of Thyroid Cancer

Resource links provided by NLM:


Further study details as provided by Guangdong General Hospital:

Estimated Enrollment: 2000
Study Start Date: February 2010
Groups/Cohorts
Compuer radiaton group
control group

  Eligibility

Ages Eligible for Study:   10 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The population of city of Guangdong province

Criteria

Inclusion Criteria:

  • Thyroid cancer

Exclusion Criteria:

  • Non-Thyroid cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01043107

Contacts
Contact: Zhe Chen, MD 0086-20-83827812 chenzhe_cmu@hotmail.com

Locations
China, Guangdong
Guangdong General Hospital Not yet recruiting
Guangzhou, Guangdong, China, 510080
Contact: Zhe Chen    0086-20-3827812    chenzhe_cmu@hotmial.com   
Sponsors and Collaborators
Guangdong General Hospital
  More Information

No publications provided

Responsible Party: Yilong Wu, GGH
ClinicalTrials.gov Identifier: NCT01043107     History of Changes
Other Study ID Numbers: CancerRe-008, 83827218
Study First Received: January 5, 2010
Last Updated: February 4, 2010
Health Authority: China:Ethics Committee of GGH

Additional relevant MeSH terms:
Thyroid Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Head and Neck Neoplasms
Neoplasms
Neoplasms by Site
Thyroid Diseases

ClinicalTrials.gov processed this record on November 20, 2014